Icosagen is a biotechnology company in Estonia providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. As of March 2009, Quattromed has been renamed Icosagen AS.
Products and services
Icosagen’s activities are divided into three branches: medical diagnostics division, technology development division, and life science products division. Its main focus is in gene expression and protein production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trademark.
Icosagen’s main products are:
- FITkit (latex allergen test) and FITkit testing service
- E2Tag epitope tagging technology
- MAbs to HIV/SIV proteins, epitope tags
- anti-IgG antibodies
- QMCF Technology – a propriety protein production technology (further information)